InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Selhorn Ryan J. Director active across 1 company, notably Aytu Biopharma, INC. In total, 4 disclosures have been published. Activity tracked since 11 November 2024. The latest transaction was disclosed on 3 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations